Search

Author/Creator Kang, Jin-Hyoung

1. A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer. (24th August 2015)

Authors:
Lee, Keun-Wook; Koh, Youngil; Kim, Sung-Bae; Shin, Sang-Won; Kang, Jin-Hyoung; Wu, Hong-Gyun; Sung, Myung-Whun; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Kim, Kwang Hyun; Kwon, Tack-Kyun; Hah, J. Hun; Kim, In-Ah; Ahn, Soon-Hyun; Yoon, Dok Hyun; Lee, Sang-Wook; Kim, Sang Yoon; Nam, Soon Yuhl; Ju...
Journal:
Oncologist
Issue:
Volume 20:Number 10(2015)
Page Start:
1119
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141. (October 2017)

Authors:
Kiyota, Naomi; Hasegawa, Yasuhisa; Takahashi, Shunji; Yokota, Tomoya; Yen, Chia-Jui; Iwae, Shigemichi; Shimizu, Yasushi; Hong, Ruey-Long; Goto, Masahiro; Kang, Jin-Hyoung; Sum Kenneth Li, Wing; Ferris, Robert L.; Gillison, Maura; Namba, Yoshinobu; Monga, Manish; Lynch, Mark; Tahara, Makoto
Journal:
Oral oncology
Issue:
Volume 73(2017)
Page Start:
138
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study. Issue 12 (December 2016)

Authors:
Goss, Glenwood; Tsai, Chun-Ming; Shepherd, Frances A; Bazhenova, Lyudmila; Lee, Jong Seok; Chang, Gee-Chen; Crino, Lucio; Satouchi, Miyako; Chu, Quincy; Hida, Toyoaki; Han, Ji-Youn; Juan, Oscar; Dunphy, Frank; Nishio, Makoto; Kang, Jin-Hyoung; Majem, Margarita; Mann, Helen; Cantarini, Mireille; G...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 12(2016:Dec.)
Page Start:
1643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21. (28th October 2015)

Authors:
Kim, Hyo Jung; Shin, Sang Won; Song, Eun-Kee; Lee, Na-Ri; Kim, Jun Suk; Ahn, Jin Seok; Yun, Hwan-Jung; Cho, Yo-Han; Park, Keon Uk; Kim, Si-Young; Jang, Joung Soon; Kim, Sang-We; Lee, Hyun Woo; Lee, Se Ryeon; Kim, Yang Soo; Lee, Soon Nam; Ko, Yoon Ho; Kim, Hwa Jung; Kang, Jin-Hyoung
Journal:
Oncologist
Issue:
Volume 20:Number 12(2015)
Page Start:
1440
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2019)

Authors:
Nakagawa, Kazuhiko; Garon, Edward B; Seto, Takashi; Nishio, Makoto; Ponce Aix, Santiago; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Imamura, Fumio; Yoh, Kiyotaka; Shih, Jin-Yuan; Au, Kwok Hung; Moro-Sibilot, Denis; Enatsu, Sotaro; Zimmermann, Annamaria; Frimod...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 12(2019)
Page Start:
1655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study. (18th January 2021)

Authors:
Bang, Soo-Mee; Kang, Jin-Hyoung; Hong, Min Hee; Ahn, Jin-Seok; Oh, So Yeon; Baek, Jin Ho; Choi, Yoon Ji; Shin, Seong Hoon; Kim, Young-Joo; Gil, Ha-Yeong; Park, Hyung-Eun; Lee, Juneyoung; Park, Eun-Lyeong
Journal:
Clinical and applied thrombosis/hemostasis
Issue:
Volume 27(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗